{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:16:08Z","timestamp":1790496968461,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.jamda.2006.09.005","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T15:23:19Z","timestamp":1163517799000},"page":"S7-S12","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Practical Approach to the Diagnosis and Treatment of Anemia Associated With CKD in Elderly"],"prefix":"10.1016","volume":"7","author":[{"given":"Anil K.","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2006.09.005_bib1","series-title":"Heart disease and stroke statistics","year":"2006"},{"key":"10.1016\/j.jamda.2006.09.005_bib2","series-title":"The Principles and Practice of Nephrology","first-page":"622","article-title":"Progression of chronic renal disease: mechanisms, risk factors, and testing of interventions","author":"Hunsicker","year":"1995"},{"key":"10.1016\/j.jamda.2006.09.005_bib3","first-page":"1","volume":"28","author":"Esbach","year":"1985","journal-title":"Anemia of end-stage renal disease"},{"issue":"Suppl","key":"10.1016\/j.jamda.2006.09.005_bib4","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1046\/j.1523-1755.2001.07821.x","article-title":"Role of uremic toxins in exacerbating anemia in renal failure","volume":"78","author":"MacDougall","year":"2001","journal-title":"Kidney Int"},{"issue":"Suppl 4","key":"10.1016\/j.jamda.2006.09.005_bib5","first-page":"S1","article-title":"KEEP: Kidney Early Evaluation Program. Annual Data Report","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 5","key":"10.1016\/j.jamda.2006.09.005_bib6","first-page":"2","article-title":"Is it time for a paradigm shift?","volume":"17","author":"Eschbach","year":"2002","journal-title":"Is erythropoietin deficiency still the main cause of renal anaemia? Nephrol Dial Transplant"},{"key":"10.1016\/j.jamda.2006.09.005_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V54.4.877.877","article-title":"Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function","volume":"54","author":"Radtke","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.jamda.2006.09.005_bib8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1681\/ASN.V1081793","article-title":"Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States","volume":"10","author":"Obrador","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jamda.2006.09.005_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3949\/ccjm.73.3.289","article-title":"Anemia in chronic kidney disease: causes, diagnosis, treatment","volume":"3","author":"Nurko","year":"2006","journal-title":"Cleveland Clinic J Med"},{"key":"10.1016\/j.jamda.2006.09.005_bib10","first-page":"328","article-title":"The losartan renal protection study: rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with Angiotensin II Antagonist Losartan)","volume":"1","author":"Brenner","year":"2000","journal-title":"J Ren Ang Ald Sys"},{"issue":"1 Suppl 1","key":"10.1016\/j.jamda.2006.09.005_bib11","first-page":"S182","article-title":"NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jamda.2006.09.005_bib12","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ndt\/gfh1032","article-title":"European Best Practice Guidelines Working Group","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jamda.2006.09.005_bib13","series-title":"Iron deficiency anaemia: assessment, prevention, and control","year":"2001"},{"key":"10.1016\/j.jamda.2006.09.005_bib14","first-page":"758","article-title":"Anemia of chronic kidney disease: A combined effect of marginal iron stores and erythropoietin deficiency","volume":"33","author":"Schwartz","year":"2004","journal-title":"Dialysis Transplant"},{"key":"10.1016\/j.jamda.2006.09.005_bib15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjmed.2005.01.065","article-title":"Are we giving too much iron? Low-dose iron therapy is effective in octogenarians","volume":"118","author":"Rimon","year":"2005","journal-title":"Am J Med"},{"issue":"Suppl","key":"10.1016\/j.jamda.2006.09.005_bib16","first-page":"S65","article-title":"Iron metabolism in rhEPO-treated hemodialysis patients","volume":"53","author":"Schaefer","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jamda.2006.09.005_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt799","article-title":"Enhancement of therapeutic protein in vivo activities through glycoengineering","volume":"21","author":"Elliot","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jamda.2006.09.005_bib18","unstructured":"Erythropoetin (Epogen\/Procrit) [package insert]. Raritan (NJ): Ortho Biotech Products, LP; 2005. Available at: http:\/\/www.epogen.com\/pdf\/epogen_pi.pdf. Accessed August 16, 2006."},{"key":"10.1016\/j.jamda.2006.09.005_bib19","unstructured":"Darbepoetin (Aranesp) [package insert]. Thousand Oaks (CA): Amgen Inc.; 2005.Available at: http:\/\/www.aranesp.com\/pdf\/aranesp_PI.pdf Accessed August 16, 2006."},{"key":"10.1016\/j.jamda.2006.09.005_bib20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/ndt\/gfh021","article-title":"Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients","volume":"19","author":"Jadoul","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jamda.2006.09.005_bib21","series-title":"Aranesp (darbepoetin alfa) administered once monthly maintains hemoglobin levels in patient with chronic kidney disease (CKD)","author":"Agarwal","year":"2004"},{"issue":"Suppl 1","key":"10.1016\/j.jamda.2006.09.005_bib22","first-page":"s25","article-title":"Comparative analysis of efficacy and safety of once-weekly (QW) epoetin alfa (EPO) in elderly (\u226565) and non-elderly (<65) patients with anemia due to chronic kidney disease (CKD)","volume":"52","author":"Fink","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2006.09.005_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5414\/CNP64113","article-title":"Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study","volume":"64","author":"Provenzano","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jamda.2006.09.005_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000092852","article-title":"Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from Simplify the Treatment of Anemia with Aranesp (STAAR)","volume":"26","author":"Hertel","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jamda.2006.09.005_bib25","series-title":"Once-monthly Aranesp (darbepoetin alfa) maintains hemoglobin in elderly chronic kidney disease patients","author":"Ling","year":"2005"},{"key":"10.1016\/j.jamda.2006.09.005_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP63327","article-title":"Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease","volume":"63","author":"Ling","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jamda.2006.09.005_bib27","unstructured":"Agarwal A, Silver MR, Walczyk M, Liu W, Audhy P. Once-monthly darbepoetin alfa for maintaining hemoglobin levels in older patients with chronic kidney disease. J Am Med Dir Assoc; in press."},{"key":"10.1016\/j.jamda.2006.09.005_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V54.4.877.877","article-title":"Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory function","volume":"54","author":"Radtke","year":"1979","journal-title":"Blood"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861006004580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861006004580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T18:48:18Z","timestamp":1628102898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861006004580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1525861006004580"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2006.09.005","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}